JP2020531586A5 - - Google Patents

Download PDF

Info

Publication number
JP2020531586A5
JP2020531586A5 JP2020532845A JP2020532845A JP2020531586A5 JP 2020531586 A5 JP2020531586 A5 JP 2020531586A5 JP 2020532845 A JP2020532845 A JP 2020532845A JP 2020532845 A JP2020532845 A JP 2020532845A JP 2020531586 A5 JP2020531586 A5 JP 2020531586A5
Authority
JP
Japan
Prior art keywords
derivative
composition
synthetic lysine
synthetic
analog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2020532845A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020531586A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/046023 external-priority patent/WO2019045989A1/en
Publication of JP2020531586A publication Critical patent/JP2020531586A/ja
Publication of JP2020531586A5 publication Critical patent/JP2020531586A5/ja
Priority to JP2023088440A priority Critical patent/JP2023123440A/ja
Priority to JP2025129144A priority patent/JP2025166032A/ja
Withdrawn legal-status Critical Current

Links

JP2020532845A 2017-08-27 2018-08-09 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物 Withdrawn JP2020531586A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023088440A JP2023123440A (ja) 2017-08-27 2023-05-30 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物
JP2025129144A JP2025166032A (ja) 2017-08-27 2025-08-01 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762550656P 2017-08-27 2017-08-27
US62/550,656 2017-08-27
US201862664555P 2018-04-30 2018-04-30
US62/664,555 2018-04-30
PCT/US2018/046023 WO2019045989A1 (en) 2017-08-27 2018-08-09 METHODS AND COMPOSITIONS FOR THE ANTIVIRAL USE OF LYSINE SYNTHETIC ANALOGUES AND MIMETICS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023088440A Division JP2023123440A (ja) 2017-08-27 2023-05-30 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物

Publications (2)

Publication Number Publication Date
JP2020531586A JP2020531586A (ja) 2020-11-05
JP2020531586A5 true JP2020531586A5 (enExample) 2021-09-16

Family

ID=65525881

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020532845A Withdrawn JP2020531586A (ja) 2017-08-27 2018-08-09 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物
JP2023088440A Withdrawn JP2023123440A (ja) 2017-08-27 2023-05-30 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物
JP2025129144A Pending JP2025166032A (ja) 2017-08-27 2025-08-01 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023088440A Withdrawn JP2023123440A (ja) 2017-08-27 2023-05-30 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物
JP2025129144A Pending JP2025166032A (ja) 2017-08-27 2025-08-01 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物

Country Status (11)

Country Link
US (3) US11413279B2 (enExample)
EP (2) EP4681713A2 (enExample)
JP (3) JP2020531586A (enExample)
KR (1) KR102706114B1 (enExample)
CN (1) CN111315374A (enExample)
AU (2) AU2018324427B2 (enExample)
BR (1) BR112020003735A2 (enExample)
CA (1) CA3073685A1 (enExample)
MX (2) MX2020002156A (enExample)
WO (1) WO2019045989A1 (enExample)
ZA (1) ZA202001472B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220249416A1 (en) * 2019-10-29 2022-08-11 Tranexamic Technologies, Llc Synergistic combinations of synthetic lysine analogs, derivatives, mimetics, or prodrugs and pharmaceutical agents for enhanced efficacy
WO2021162879A1 (en) * 2020-02-14 2021-08-19 Tranexamic Technologies, Llc Methods and compositions for antimicrobial use of synthetic lysine analogs, derivatives, mimetics, and prodrugs
JP7830159B2 (ja) * 2021-02-26 2026-03-16 ライオン株式会社 コロナウイルスの細胞侵入抑制剤
EP4659805A3 (en) 2022-02-09 2026-04-01 Galen Limited Concentrated injectable tranexamic acid compositions and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69524971T2 (de) * 1994-10-28 2002-08-29 Vitaleech Bioscience N.V., Rotterdam Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen
AU1773600A (en) * 1998-12-21 2000-07-12 Aps Kbus 8 Nr. 4788 Topical treatment of skin disease
ES2156731B1 (es) * 1999-05-31 2002-02-16 Grifols Grupo Sa Utilizacion del acido tranexamico para la preparacion de una composicion de fibrinogeno humano.
US7056947B2 (en) * 2002-07-05 2006-06-06 Georgia Tech Research Corp. Aza-peptide epoxides
AU2003272974A1 (en) * 2002-10-11 2004-05-04 Daiichi Pharmaceutical Co., Ltd. Anti-influenza virus agent
JP2008115168A (ja) * 2006-10-12 2008-05-22 Daiichi Sankyo Healthcare Co Ltd 抗アデノウイルス剤
CA2742817A1 (en) * 2008-11-20 2010-05-27 Biogen Idec Ma Inc. Arginine inactivation of viruses
JP2010189301A (ja) * 2009-02-17 2010-09-02 Toshihito Eto 新型インフルエンザ感染症に対する医薬組成物およびその利用
US20120082677A1 (en) * 2010-10-01 2012-04-05 Sherif Salah Abdul Aziz Compositions for the treatment of hcv and hbv
US20140271923A1 (en) * 2013-03-14 2014-09-18 Christopher Brian Reid Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
CN103405384B (zh) * 2013-09-01 2015-05-13 吴静 氨甲环酸的药物组合物

Similar Documents

Publication Publication Date Title
US9642895B2 (en) Peptides for enhancing transdermal delivery
JP2022512478A5 (enExample)
MY208749A (en) Biligand drug conjugates and uses thereof
JP2013515739A5 (enExample)
RU2012131251A (ru) Композиции и способы для лечения связанных с ангиогенезом заболеваний глаз
ITMI20101459A1 (it) Composizione comprendente glutatione reduttasi e glutatione ossidato
RU2013117209A (ru) Буферные глазные композиции и способы их применения
AR093481A1 (es) Parche de varios dias para la administracion transdermica de rotigotina
EP4620525A3 (en) Methods and compositions for treatment of pulmonary hypertension and other lung disorders
UA107578C2 (uk) Комбінована терапія при лікуванні діабету
BR112015025804A2 (pt) derivados de glutarimida, uso dos mesmos, composição farmacêutica com base neles e métodos para a produção de derivados de glutarimida
RU2015122627A (ru) Кожные композиции, содержащие неприродные гигроскопические аминокислоты
JP2013519653A5 (enExample)
WO2008082507A3 (en) Pharmaceutical compositions and method for treating inflammation in cattle and other animals
WO2024169972A1 (en) New multi-functional oligopeptides
JP2025166032A (ja) 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物
MX2017004476A (es) Composicion que comprende al menos un polvo seco obtenido por secado por atomizacion para aumentar la estabilidad de la formulacion.
CN102066402A (zh) 肽衍生物以及含有肽衍生物的用于促进泪液分泌的组合物
JP2025166032A5 (enExample)
JP2009506978A5 (enExample)
JP2016515137A5 (enExample)
EA201591653A1 (ru) Композиции для лечения глазных расстройств с применением дипиридамола
HRP20161006T1 (hr) Postupak liječenja kožnih poremećaja
RU2014136096A (ru) Лекарственное средство для лечения и профилактики заболеваний верхних и нижних дыхательных путей различной этиологии, его применение и метод лечения на его основе
KR20260030114A (ko) 신규한 다기능성 올리고펩타이드